Rajasthan Suspends Specific Batch of Bupivacaine Injection After Adverse Reactions
The Rajasthan Drug Control Department has suspended the sale and use of a specific batch (BKP02601) of Bupivacaine Hydrochloride in Dextrose injection, following reports of serious adverse reactions in 16 patients in Hyderabad. This local anaesthetic is commonly used in surgeries, including cesarean sections and dental procedures. Authorities emphasize that the suspension applies only to this batch, with alternative anaesthesia options available. Investigations are ongoing, and patients are advised to consult medical professionals without delaying necessary surgeries.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is neutral (42/100). Lens Score 35/100 — moderate-to-low public interest.
Outlets analysed (first-hand measurement by TBN's Bias Engine):
- news18— balanced framing, neutral sentiment
- timesnow— balanced framing, negative sentiment
AI Analysis
The articles present a straightforward report focusing on health and safety concerns without political framing. They include official actions by the Rajasthan Drug Control Department and expert clarifications, reflecting a neutral stance. The coverage centers on patient safety and regulatory response, with no evident political viewpoints or partisan interpretations.
The tone across the articles is cautious and informative, emphasizing precaution and patient safety. While reporting adverse reactions, the language avoids alarmism, highlighting ongoing investigations and available alternatives. The overall sentiment is neutral to slightly concerned, aiming to inform without causing undue panic.
How 2 sources covered this story
Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.